Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-044551
Filing Date
2024-10-31
Accepted
2024-10-31 16:06:05
Documents
86
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20240930.htm   iXBRL 10-Q 1695139
2 EX-10.2 exhibit102-xhovionecommerc.htm EX-10.2 293672
3 EX-10.5 exhibit105-xardelyxxfourth.htm EX-10.5 130934
4 EX-10.6 exhibit106-xericfosteroffe.htm EX-10.6 15951
5 EX-31.1 ardx-20240930xex311.htm EX-31.1 9758
6 EX-31.2 ardx-20240930xex312.htm EX-31.2 9780
7 EX-32.1 ardx-20240930xex321.htm EX-32.1 6466
13 ardx-20240930_g1.jpg GRAPHIC 75659
14 image_0.jpg GRAPHIC 49118
  Complete submission text file 0001628280-24-044551.txt   8731333

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20240930.xsd EX-101.SCH 59004
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20240930_cal.xml EX-101.CAL 68516
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20240930_def.xml EX-101.DEF 261013
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20240930_lab.xml EX-101.LAB 698698
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20240930_pre.xml EX-101.PRE 479894
89 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20240930_htm.xml XML 1087329
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 241415240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)